<DOC>
	<DOCNO>NCT01793324</DOCNO>
	<brief_summary>A study evaluate effectiveness update educational material respect evaluation monitoring metabolic parameter</brief_summary>
	<brief_title>EMR Data Assess Monitoring Patients Treated With Quetiapine</brief_title>
	<detailed_description>Objective assessment metabolic monitoring patient treat Seroquel® Seroquel® XR/quetiapine fumarate : use IMS Disease Analyzer ass physician behaviour UK Germany</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Electronic medical record patient diagnosis schizophrenia , Bipolar Disorder ( BPD ) Major Depressive Disorder ( MDD ) treat Seroquel® Seroquel®XR calendar period : 13 Feb 31 Aug 2012 see GP &amp; psychiatrist Germany &amp; 11 Jan31 July 2012 see GPs UK Patients mention diagnosis treat Seroquel® Seroquel® XR/quetiapine fumarate medical encounter time period : 13 Feb 31 Aug 2012 Germany &amp; 11 Jan31 July 2012 GPs UK</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Effectiveness risk minimization</keyword>
	<keyword>Metabolic monitoring</keyword>
	<keyword>Seroquel® Seroquel® XR/quetiapine fumarate</keyword>
</DOC>